| 产品描述： | 文拉法辛的异构体;an isomer of Venlafaxine;D，L-文拉法辛是文拉法辛的异构体。文拉法辛是苯乙胺的衍生物，据报道可通过阻止神经胺如5-羟色胺（5-羟色胺； 5-HT）和去甲肾上腺素（去甲肾上腺素）的突触前再摄取来促进中枢神经系统内的神经传递。还报道了Velanfaxine是多巴胺再摄取的弱抑制剂。|体外研究表明，Venlafaxine对毒蕈碱，组胺能或α-1肾上腺素受体没有明显的活性。据报道，文拉法辛的代谢是通过细胞色素P450（CYP）酶CYP2D6发生的，产生O-去甲基文拉法辛。CYP3A4产生较少的代谢产物N-去甲基文拉法辛。;D,L-Venlafaxine is an isomer of Venlafaxine . Venlafaxine is a derivative of phenylethylamine which is reported to facilitate neurotransmission within the central nervous system via blocking the presynaptic reuptake of neuroamines such as serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine). Velanfaxine is also reported to be a weak inhibitor of dopamine reuptake.|In vitro|studies indicate that Venlafaxine does not demonstrate significant activity for muscarinic, histaminergic or α-1 adrenergic receptors. The metabolism of venlafaxine is reported to occur by cytochrome P450 (CYP) enzyme CYP2D6 yielding O-desmethylvenlafaxine. A lesser metabolite, N-desmethylvenlafaxine is produced by CYP3A4. |
| 体内研究： |
Venlafaxine (Wy 45030; 10-100 mg/kg; IP) dose-dependently blocks the depletion of norepinephrine levels in rat hypothalamus induced by 6-OHDA. |
| 保存条件： |
-80℃（运输条件：冰袋低温运输） |
| 配置溶液浓度参考： |
|
1mg |
5mg |
10mg |
| 1 mM |
3.605 ml |
18.025 ml |
36.049 ml |
| 5 mM |
0.721 ml |
3.605 ml |
7.21 ml |
| 10 mM |
0.36 ml |
1.802 ml |
3.605 ml |
| 50 mM |
0.072 ml |
0.36 ml |
0.721 ml |
|
| 注意： |
部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京